In-vitro Fertilization Microscopes Market Size, Share & Trends Analysis Report By End-use (Clinical, Academic Research), By Region (North America, Europe, APAC, LATAM, MEA), And Segment Forecasts, 2022 - 2030

Report Overview

The global in-vitro fertilization microscopes market size was valued at USD 94.0 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 8.4% from 2022 to 2030. In-vitro fertilization microscopes are used for various procedures, such as semen analysis, oocyte preparation, in-vitro fertilization, and the overall analysis of the embryo. The improving success rate of in-vitro fertilization procedures and the availability of financial assistance are expected to boost the market growth. Furthermore, product innovations by manufacturers are increasing treatment efficiency and are expected to reduce procedure costs. Improved quality of microscopic examination by high contrast and innovations in the IVF microscope-related equipment are some of the important advancements in the market.

For instance, the Indian Institute of Technology (IIT) Hyderabad received funding from the Department of Science and Technology (DST), Government of India, for the development of an IoT-based 3D printed Time-lapse smart microscope for embryo monitoring in IVF clinics.

The removal of embryos from an optimized culture environment to inspect for cleavage and morphology increases stress, thus limiting the number of assessments that can be performed. The system used for embryo monitoring by time-lapse technology incorporates a microscope and camera inside the incubation system, which enables noninvasive microscopic imaging of the embryo at specific time intervals. In March 2019, Olympus Corporation and Jikei University School of Medicine collaborated to develop the AI-assisted sperm selection process to reduce the overall time required for Intracytoplasmic Sperm Injection (ICSI) procedure.

COVID-19 In-vitro fertilization microscopes market impact: 7.9% increase from 2020 to 2021

The rising prevalence of infertility among men and women is expected to foster the growth of the market for IVF microscopes during the forecast period. According to the World Health Organization data, approximately 186 million people and around 48 million couples are suffering from infertility globally. According to the US Society of Assisted Reproductive Technology (SART), approximately 0.29 million IVF cycles were initiated in the US in 2020.

The companies operating in the market for IVF microscopes have to follow the guidelines led by the authorities such as the American Society for Reproductive Medicine, the European Society of Human Reproduction and Embryology, and others. Considering the increasing awareness about IVF services, developing nations have also taken measures to introduce regulations. For instance, in India, the Assisted Reproductive Technology (Regulation) Act, 2008, categorizes infertility clinics into three levels and provides requirements they need to meet. It requires the embryology laboratory complex to house a stereo microscope, a micromanipulator for performing ICSI, and a high-resolution inverted microscope with Hoffman optics or phase contrast.

End-use Insights

The clinical segment dominated the market for IVF microscopes and accounted for the largest revenue share of 94.6% in 2021 and is expected to witness the fastest growth during the forecast period. Major factors contributing to the segment growth include increasing awareness regarding IVF treatment and growing investments by private investors in infertility clinics. The rising use of a variety of microscopes in clinical ART procedures is expected to boost the growth of the segment during the forecast period. Microscopes are used in clinical ART facilities to accomplish gamete selection and clinical procedures. Stereo microscopes are used to analyze oocyte and embryo morphology and viability, while upright microscopes are used to visualize and test sperm morphology, motility, and viability. While both types of microscopes are used in clinical settings, ones with an inverted design are the most adaptable for ART.

IVF clinics provide a range of services, including healthy oocyte identification, semen analysis, ICSI, embryo monitoring, and freezing and storage of embryos. There is a trend of innovating products for use in IVF clinics and receiving investments from private investors in IVF clinics. In November 2019, a fertility tech startup, Mojo, received funding of around USD 1.8 million. The startup is working on a combination of AI software and microscopy hardware, a product to assist in sperm selection by focusing on the count, morphology, and speed of the sperm.

Regional Insights

Europe dominated the in-vitro fertilization microscopes market and accounted for the largest revenue share of 24.5% in 2021 due to factors such as growing fertility tourism, legal reforms, and product innovation. The region has observed a significant adoption of time-lapse technology with clinic-designed algorithms. Innovation in microscopes providing all imaging requirements used in a single embryo chamber to reduce the requirement of multiple workstations is aiding in saving space and cost of the procedure.

Companies operating in the region are adopting various strategies including product launches, research initiatives, and others to propel the growth of the market for IVF microscopes during the forecast. For instance, in August 2021, Nikon Microscopes launched ECLIPSE Ti2-U IVF for the early procedures in the Intracytoplasmic Sperm Injection (ICSI). In Asia Pacific, the market for IVF microscopes is expected to witness the fastest growth over the forecast period owing to key factors such as increasing awareness and availability of IVF services. The presence of a large population and increasing awareness regarding IVF are among the key factors contributing to the increased demand for microscopes by clinics.

Key Companies & Market Share Insights

Established players are adopting strategies such as geographic expansion and product innovation by integrating the latest technology. For instance, in June 2020, Zeiss and Hamilton Throne joined the Global Fertility Alliance. Global Fertility Alliance is dedicated to assisting standardization of the processes required for the ART (Assisted Reproductive Treatment) laboratories. Merck KGaA, Illumina Inc., and Genea Limited are the existing members of the alliance. Some of the prominent players in the in-vitro fertilization microscopes market include:

• Linkam Scientific Instruments

• Olympus Corporation

• Leica Microsystems

• Meiji Techno

• Zeiss

• Euromex Microscopen B.V.

• Labomed Europe B.V.

• Nikon Corporation

• Narishige Group

• Eppendorf AG

• Hamilton Thorne Ltd.

• Sutter Instrument Company

• Tritech Research, Inc.

 In-vitro Fertilization Microscopes Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global in-vitro fertilization microscopes market report on the basis of end-use and region:

• End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Clinical

  • Academic Research

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

  • Latin America

    • Mexico

    • Brazil

  • Middle East & Africa (MEA)

    • South Africa